Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Associated-Onset Symptoms and Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors Infected with Wuhan, Alpha or Delta SARS-CoV-2 Variant
César Fernández‐de‐las‐Peñas, Ignacio Cancela‐Cilleruelo, Jorge Rodríguez‐Jiménez, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 725-725
Open Access | Times Cited: 52
Dual-Gene-Controlled Rolling Circle Amplification Strategy for SARS-CoV-2 Analysis
Ying Deng, Tianci Zhou, Ying Peng, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 6, pp. 3358-3362
Closed Access | Times Cited: 27
Consistency of inconsistency in long‐COVID‐19 pain symptoms persistency: A systematic review and meta‐analysis
Oleg Kerzhner, Einat Berla, Meirav Har‐Even, et al.
Pain Practice (2023) Vol. 24, Iss. 1, pp. 120-159
Open Access | Times Cited: 24
Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms
Ann‐Charlotte Granholm
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3190-3190
Open Access | Times Cited: 22
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
Beatrice Ragnoli, Beatrice Da Re, Alessandra Galantino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8945-8945
Open Access | Times Cited: 21
Mechanisms underlying the synergistic effects of chuanxiong combined with Chishao on treating acute lung injury based on network pharmacology and molecular docking combined with preclinical evaluation
Junling Gao, Ning Wang, Wenjuan Song, et al.
Journal of Ethnopharmacology (2024) Vol. 325, pp. 117862-117862
Closed Access | Times Cited: 7
Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
Trevor J. Plowman, Hannah Christensen, Myia Aiges, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5190-5190
Open Access | Times Cited: 7
Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients
Laura E. Martínez-Gómez, Isabel Ibarra‐González, Cynthia Fernández‐Lainez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Oral Lesions in Pediatric Subjects: SARS-CoV-2 Infection and COVID-19 Vaccination
Federica Di Spirito, Mario Caggiano, Maria Pia Di Palo, et al.
Applied Sciences (2022) Vol. 12, Iss. 18, pp. 8995-8995
Open Access | Times Cited: 27
The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence
Anna Paola Capra, Alessio Ardizzone, Giuseppe Pantò, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3537-3537
Open Access | Times Cited: 19
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis
Haokun Tian, Changsen Yang, Tiangang Song, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 17
Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks
Muhammad Hakimin Shafie, Marie Antony Dass, Hazlam Shamin Ahmad Shaberi, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital
Mohammed Taleb, Abdelraouf A. Elmanama, Alaa H Taleb, et al.
The Journal of Infection in Developing Countries (2023) Vol. 17, Iss. 05, pp. 597-609
Open Access | Times Cited: 15
The Immune Response of OAS1, IRF9, and IFI6 Genes in the Pathogenesis of COVID-19
Malena Gajate-Arenas, Ingrid Fricke-Galindo, Omar García-Pérez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4632-4632
Open Access | Times Cited: 5
Epidemiological characterization of COVID-19 in children under 18 years old in Mexico: an analysis of the pandemic
Isamu Daniel Takane-Cabrera, Fanny Yasmin Ortega-Vargas, Ilen Adriana Díaz-Torres, et al.
Frontiers in Pediatrics (2025) Vol. 12
Open Access
COVID-19 and Myocarditis: Pathogenetic Mechanisms and Histological Features
Cecilia Salzillo, Andrea Marzullo
Deleted Journal (2025) Vol. 70, Iss. 1, pp. 3-3
Open Access
Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study
Behnam Maleki, Amir M. Sadeghian, Mitra Ranjbar
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Late-Onset Urticarial and Erythema Multiforme-Like Eruption Following SARS-CoV-2 Infection
Barbara S Suening, Molly E Boyko, Albert Starr, et al.
Cureus (2025)
Open Access
High COVID-19 Vaccine Hesitancy Among Healthcare Workers: Should Such a Trend Require Closer Attention by Policymakers?
Narmada Ashok, Kandamaran Krishnamurthy, Keerti Singh, et al.
Cureus (2021)
Open Access | Times Cited: 34
Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study
Kuat Oshakbayev, Zulfiya Zhankalova, Meruyert Gazaliyeva, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 255-260
Open Access | Times Cited: 25
Intensive care unit‐acquired weakness and the COVID‐19 pandemic: A clinical review
Evelyn S. Qin, Catherine L. Hough, James S. Andrews, et al.
PM&R (2022) Vol. 14, Iss. 2, pp. 227-238
Open Access | Times Cited: 25
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh
A. B. M. Muksudul Alam, Md Anwarul Azim Majumder, Mainul Haque, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 9, pp. 1167-1175
Closed Access | Times Cited: 28
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis
Εfstathia Liatsou, Ioannis Ntanasis‐Stathopoulos, Stavros Lykos, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2266-2266
Open Access | Times Cited: 10
Emerging infectious diseases, focus on infection prevention, environmental survival and germicide susceptibility: SARS-CoV-2, Mpox, and Candida auris
David J. Weber, William A. Rutala, Emily Sickbert-Bennett
American Journal of Infection Control (2023) Vol. 51, Iss. 11, pp. A22-A34
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top